Published in:
Open Access
01-07-2009 | Brief Report
Soluble Triggering Receptor Expressed on Myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia
Authors:
Guy J. Oudhuis, Judith Beuving, Dennis Bergmans, Ellen E. Stobberingh, Guul ten Velde, Catharina F. Linssen, Annelies Verbon
Published in:
Intensive Care Medicine
|
Issue 7/2009
Login to get access
Abstract
Purpose
Soluble Triggering Receptor Expressed on Myeloid cells-1 (sTREM-1) has proven to be a good biomarker for sepsis. For the diagnosis ventilator-associated pneumonia (VAP), however, there have only been a few, relatively small, studies on the role of this receptor. The aim of the study was to evaluate the usefulness of sTREM-1 in bronchoalveolar lavage fluid (BALF) from Intensive Care Unit patients as rapid diagnostic test for VAP.
Methods
The concentration of sTREM-1 in 240 BALF samples was measured using a quantitative sandwich enzyme immunoassay. Two researchers who were blind to the assay results determined whether a VAP was present or not. Clinical suspicion of a VAP was confirmed by the presence of ≥2% cells containing intracellular organisms and/or a quantitative culture result of ≥104 colony forming units per millilitre BALF.
Results
The mean concentration of sTREM-1 was significantly higher in the BALF of patients with confirmed VAP than in that of patients without confirmed VAP. However, the area under the receiver-operating characteristic curve was 0.58 (95% confidence interval 0.50–0.65, P = 0.04).
Conclusions
The results imply that the sTREM-1 assay in BALF may not be discriminative for VAP.